Deep learning-based transcriptome data classification for drug-target interaction prediction

BMC Genomics. 2018 Sep 24;19(Suppl 7):667. doi: 10.1186/s12864-018-5031-0.

Abstract

Background: The ability to predict the interaction of drugs with target proteins is essential to research and development of drug. However, the traditional experimental paradigm is costly, and previous in silico prediction paradigms have been impeded by the wide range of data platforms and data scarcity.

Results: In this paper, we modeled the prediction of drug-target interactions as a binary classification task. Using transcriptome data from the L1000 database of the LINCS project, we developed a framework based on a deep-learning algorithm to predict potential drug target interactions. Once fully trained, the model achieved over 98% training accuracy. The results of our research demonstrated that our framework could discover more reliable DTIs than found by other methods. This conclusion was validated further across platforms with a high percentage of overlapping interactions.

Conclusions: Our model's capacity of integrating transcriptome data from drugs and genes strongly suggests the strength of its potential for DTI prediction, thereby improving the drug discovery process.

Keywords: Deep learning; Drug-target interaction; LINCS project; Transcriptome data.

MeSH terms

  • Algorithms*
  • Computer Simulation
  • Databases, Factual
  • Drug Discovery
  • Drug Interactions*
  • Gene Expression Profiling / methods*
  • Humans
  • Machine Learning*
  • Models, Theoretical
  • Molecular Targeted Therapy
  • Proteins / genetics
  • Proteins / metabolism*
  • Transcriptome*

Substances

  • Proteins